Affiliation: University of Edinburgh
- When morphine does not workMarie Fallon
Edinburgh Cancer Research Centre, Western General Hospital, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XR, UK
Support Care Cancer 16:771-5. 2008..Such cancer pain can be broadly categorised as opioid irrelevant pain, opioid partially responsive pain, opioid unresponsive pain or pain resulting from excess opioid...
- Neuropathic pain in cancerM T Fallon
Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XR, UK
Br J Anaesth 111:105-11. 2013..Treating more than one symptom with a particular neuropathic pain agent can avoid polypharmacy. ..
- Terminology: the historical perspective, evolution and current usage--room for confusion?M Fallon
St Columba s Hospice Chair of Palliative Medicine, University of Edinburgh, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh, UK
Eur J Cancer 44:1069-71. 2008..Our challenges in progress involve establishing clear terminology and an evolving improved evidence base, along with a realisation that there are large gaps in patient care...
- The principles of cancer pain managementMarie Fallon
University of Edinburgh, Edinburgh Cancer Centre, Western General Hospital, Edinburgh
Clin Med 6:136-9. 2006
- A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline projectMarie T Fallon
University of Edinburgh, UK
Palliat Med 25:597-603. 2011..As opioid combination therapy becomes used increasingly, a review of the evidence on this practice was conducted...
- Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover studyMarie Fallon
Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XR, UK
J Support Oncol 9:224-31. 2011..Immediate-release morphine sulfate (IRMS) remains the standard treatment for breakthrough cancer pain (BTCP), but its onset of effect does not match the rapid onset and short duration of most BTCP episodes...
- Management of cancer pain: basic principles and neuropathic cancer painB Laird
Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK
Eur J Cancer 44:1078-82. 2008..Optimum cancer pain control is achieved by integrating standard analgesic approaches during tumouricidal therapy or any other active cancer treatment...
- Quantitative Sensory Testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of responseA C Scott
University of Edinburgh, Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK
Eur J Pain 16:123-33. 2012..No predictors of analgesic response to XRT are known. The aim of this preliminary study was to explore the effect of XRT on sensory changes in CIBP with a view to predicting response...
- Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom studyV Strong
School of Molecular and Clinical Medicine, Cancer Research UK and The University of Edinburgh Cancer Research Centre, The Western General Hospital, Crewe Road, Edinburgh EH4 2XR, UK
Br J Cancer 96:868-74. 2007..Services to treat distress in cancer patients should be organised to target patients by characteristics other than their cancer diagnosis...
- Ibandronate: its role in metastatic breast cancerDavid Cameron
Western General Hospital, Edinburgh, United Kingdom
Oncologist 11:27-33. 2006..Ibandronate is thus an effective, flexible, and well-tolerated bisphosphonate that can meet the varying requirements of patients with MBD...
- Fast-acting fentanyl preparations and pain managementK McWilliams
Department of Palliative Medicine, Edinburgh Cancer Research UK Centre, The University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XR, UK
QJM 106:887-90. 2013..The contribution of fast-acting fentanyl preparations to the treatment of breakthrough pain and the evidence for the various commercially available preparations will be considered. ..
- Translational medicine: cancer pain mechanisms and managementA Delaney
Centre for Neuroscience Research, College of Medicine and Veterinary Medicine, University of Edinburgh, Scotland, UK
Br J Anaesth 101:87-94. 2008....
- Difficult painLesley Colvin
Department of Clinical Neurosciences, Western General Hospital, Edinburgh
BMJ 332:1081-3. 2006
- Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancyC A Greig
School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh, EH16 4SB, UK
Support Care Cancer 22:1269-75. 2014..The aim of this study was to test the safety, tolerability and efficacy of a novel combination of an anabolic β2-agonist and an appetite stimulant in patients with cancer cachexia...
- Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic reviewN MacLeod
Edinburgh Cancer Research UK Centre, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK Beatson West of Scotland Cancer Centre, 1053 Great Western Rd, Glasgow G12 0YN, UK Electronic address
Lung Cancer 83:133-8. 2014..Studies focusing on clear pain endpoints and improving target delineation are needed. Such studies should also use modern radiotherapy techniques and concentrate on dose escalation. ..
- Challenges in cancer pain management--bone painL Colvin
Department of Anaesthesia, Edinburgh Cancer Research Centre, St Columba s Hospice Chair of Palliative Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Crewe Road South, Edinburgh, UK
Eur J Cancer 44:1083-90. 2008..Potential adjuvants to standard analgesic therapies for CIBP are being explored in clinical trials and include inhibitors of glutamate release...
- Principles of control of cancer painMarie Fallon
Share Zedek Medical Centre, Jerusalem, Israel
BMJ 332:1022-4. 2006
- From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, mentholLeslie A Colvin
J Clin Oncol 26:4519-20. 2008
- Opioid-induced hyperalgesia: fact or fiction?Marie Fallon
Palliat Med 22:5-6. 2008
- Other ways in palliative careMarie Fallon
Eur J Cancer 42:2667. 2006
- Palliative care--or is it?Marie Fallon
Palliat Med 16:1-3. 2002